MitchellSmithDOMS

Clinical Trials

• Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis Start of enrollment: 2019 Oct 15

  Active, not recruiting

  Phase 2

• A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum Start of enrollment: 2018 Jan 24

  Completed

  Phase 2

• Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo Start of enrollment: 2021 Mar 04

  Terminated

  Phase 2

• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines Start of enrollment: 2021 Nov 30

  Completed

  Phase 3

• An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib Start of enrollment: 2022 Dec 09

  Recruiting

  Phase 3

• A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria Start of enrollment: 2022 Oct 26

  Active, not recruiting

  Phase 2

• Join now to see all